Recent development in hypertension gene study
- Author:
Ru-tai HUI
1
;
Tao KONG
1
;
Sheng ZHAO
;
Lei SONG
1
;
Li-hong ZHANG
1
;
Jing-zhou CHEN
1
;
Wei-li ZHANG
1
;
Yi-bo WANG
1
;
Zhe LIU
;
Qing HOU
;
Ying-xian SUN
Author Information
- Publication Type:Journal Article
- Keywords: hypertension; gene
- From: Chinese Journal of Practical Internal Medicine 2019;39(01):27-37
- CountryChina
- Language:Chinese
- Abstract: Genetic as well as genomic study has advanced the development of precision medicine. We are marching on the road for right patients who are receiving more and more right treatment at right time. In hypertension field, precision medicine is available, actionable and affordable. First and the most practical advancement is monogenic hypertension, the disease-genes have been found for at least 17 types of monogenic hypertension. These patients can be precisely treated according to their carried gene mutation. Secondly, pharmacogenetic and pharmacogenomic guided anti-hypertensive drug selection, very promising but lack of clinic outcome data to support widely clinical application. Majority of hypertension are due to multiple genetic and environmental factors. GWAS fund some genetic variants related to primary hypertension, but these variants can only be responsible for 1-10% of blood pressure variation. We have a long way to go in exploring the real cause of primary hypertension.
